ESCRS - Zeiss acquires Veracity ;
ESCRS - Zeiss acquires Veracity ;

Zeiss acquires Veracity

Veracity is a  platform for cataract surgical planning, management and analysis

Zeiss acquires Veracity
Colin Kerr
Colin Kerr
Published: Tuesday, August 22, 2017
[caption id="attachment_6219" align="alignnone" width="750"]Jim Mazzo, Global President Ophthalmic Devices at Carl Zeiss Meditec. Jim Mazzo, Global President Ophthalmic Devices at Carl Zeiss Meditec.[/caption] Zeiss has acquired Veracity Innovations. Veracity, which was recently launched at the American Society of Cataract and Refractive Surgery (ASCRS) in May 2017, is a  platform for cataract surgical planning, management and analysis that allows  surgeons and their clinical teams to easily and consistently achieve the excellent outcomes their patients expect. Veracity interfaces with many Electronic Medical Records (EMR) and diagnostic devices to present the most relevant and critical data that is needed at each step – from the first initial patient consultation through the entire planning, scheduling, procedural and post-operative process. This helps doctors to streamline the clinical process, enhance productivity and efficiency, and reduce potential human error while developing a customized solution for each and every patient. “ZEISS already provides advanced digital solutions that support doctors in their clinical decisions and provide for efficient data management. Our ZEISS FORUM system with its Clinical Workplaces connects the diagnostic devices within a practice, then integrates and delivers this information from multiple modalities at the point of care – in the office and in the OR,” says Jim Mazzo, Global President Ophthalmic Devices at Carl Zeiss Meditec. “Now we are complementing this with the Veracity platform – a simple, cloud-based solution that provides doctors, and their teams, exactly the information they need at each step in the clinical process so they can work more efficiently, mitigate risks, and achieve the very best possible outcomes for their patients," said Mr Mazzo. https://www.zeiss.com/corporate/int/zeiss-corporate-newsroom/news/press-releases.html?id=acquisition-veracity-innovations_2017
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;